| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.004 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |